A JAMA Psychiatry study of 1,284 people and their relatives found that bipolar II disorder and cannabis use disorder cluster in the same families, suggesting a shared underlying vulnerability, with mood episodes typically starting before cannabis problems.
Psychiatrists; genetic researchers; families with histories of bipolar disorder or substance use.
Bipolar II in probands predicted 2.6x increased CUD risk in relatives
What the researchers found
CUD in probands was associated with increased CUD in relatives (aOR 2.64). Bipolar II (but not bipolar I or major depression) was also associated with CUD in relatives (aOR 2.57). Among relatives, CUD was associated with bipolar II (aOR 4.50) and major depression (aOR 3.64). Mood episodes typically preceded CUD onset.
Why it matters
The specific link with bipolar II (but not bipolar I) is new and clinically significant. If a shared genetic vulnerability underlies both conditions, then treating bipolar II early might actually help prevent cannabis use disorder.
The numbers in context
CUD in probands predicted CUD in relatives (aOR 2.64, 95% CI 1.20-5.79). BP-II predicted CUD in relatives (aOR 2.57, 95% CI 1.06-6.23). Rates of CUD were highest in relatives with both familial and individual BP-II history (28.6% vs 7.2% with neither). Mood episodes preceded CUD in most cases.
How the study worked
Community-based family study in the Washington, DC area (2004-2020). 586 adult probands and 698 first-degree relatives underwent semistructured diagnostic interviews. Mixed-effects models estimated familial aggregation of CUD with mood disorders, adjusting for demographics and comorbidities.
What this study cannot tell us
Cross-sectional design cannot definitively establish temporal ordering. The DC metro sample may not represent all populations. Lifetime diagnoses may be subject to recall bias. The relatively small number of CUD cases (55 probands, 68 relatives) limits statistical power for subgroup analyses.
How to read the evidence
Strong: published in JAMA Psychiatry with structured diagnostic interviews, family design, and appropriate statistical controls.
When this study was published
Published in 2022, with recruitment from 2004-2020.
The bigger picture
This adds genetic evidence to the long-debated question of whether cannabis causes mental illness or whether shared vulnerabilities drive both. The finding that mood episodes typically come first, combined with the family clustering, suggests a shared diathesis model where underlying vulnerability leads to both conditions.
Questions still open
- Would early bipolar II treatment reduce CUD onset? What specific genetic variants underlie the shared vulnerability? Does this family clustering extend to cannabis use without meeting disorder criteria?
Common questions
Does bipolar disorder cause cannabis addiction?
Why bipolar II but not bipolar I?
Read the original research
Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study.
JAMA psychiatry, 79(7), 727-735
Citation
Quick, Courtney R; Conway, Kevin P; Swendsen, Joel; Stapp, Emma K; Cui, Lihong; Merikangas, Kathleen R. (2022). Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study.. JAMA psychiatry, 79(7), 727-735. https://doi.org/10.1001/jamapsychiatry.2022.1338
Explore the wider topic
- LGBTQ+ and Cannabis: Higher Use Rates and Recovery
- Cannabis-Induced Psychosis: What It Is, Who's at Risk, and What to Do
- BetterHelp, Cerebral, and Online Therapy: Honest Review
- Quitting Weed with ADHD: Why It Is Harder and What Actually Helps
- Quitting Weed with Depression: What You Need to Know
- Quitting Weed with PTSD: A Practical Guide
- Self-Medicating with Weed: Why It Works Until It Doesn't
- Weed and OCD: Self-Medicating Intrusive Thoughts
- Weed and PTSD: What the Research Actually Shows
- Weed and Childhood Trauma: ACEs, Self-Medication, and the Path to Real Healing
- Weed and Suicidal Thoughts: What You Need to Know